Skip to main content
. 2018 Aug 30;7(9):116. doi: 10.3390/antiox7090116

Figure 10.

Figure 10

Western blot analysis of (A) Aminopeptidase N (CD13), (B) Integrin α-2 (CD49b) and (C) VDAC-1 after treatment of HUVECs with OxPAPC. Samples were treated for 0 or 90 min with a final OxPAPC concentration of 0 or 80 µmol/L. BAP31: B-cell receptor-associated protein 31 which was identified to not be modified by OxPAPC.